ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shochat, T.
Right arrow Articles by Lavie, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shochat, T.
Right arrow Articles by Lavie, P.
Eur Respir J 2001; 19:121-126
Copyright ©ERS Journals Ltd 2001


The SleepStripTM: an apnoea screener for the early detection of sleep apnoea syndrome

T. Shochat1, N. Hadas1, M. Kerkhofs2, A. Herchuelz2, T. Penzel3, J.H. Peter3 and P. Lavie4

1 Scientific Laboratory Products, Ltd., Tel Aviv, Israel. 2 Sleep Laboratory CHU A.Vésale, Free University of Brussels, Montigny-le-Tilleul, Belgium. 3 Med. Poliklinik of Philipps University, Marburg, Germany. 4 Sleep Laboratory, Technion-Israel Institute of Technology, Haifa, Israel

CORRESPONDENCE: P. Lavie, Sleep Lab, Gutwirth Building, Technion City, Haifa, Israel, 32000. Fax: 972 48323045

Keywords: apnoeas, hypopnoeas, received-operator characteristic curves, screening, SleepStrip

Received: March 23, 2001
Accepted August 2, 2001

Conflict of interest: P. Lavie is the scientific advisor to the company manufacturing the SleepStrip. N. Hadas is the company's R&D manager. T. Shochat is the Clinical Trials Director of the company. P. Lavie and N. Hadas are both shareholders in the company.

Sleep apnoea syndrome (SAS) is a largely undiagnosed and prevalent disorder. It is associated with cardiovascular morbidity as well as excessive daytime sleepiness and poor quality of life. In the present study the SleepStripTM, a novel screening device is introduced, which is low cost and easy to use and is aimed for widespread use.

The results of three independent validation studies, which compared the SleepStripTM score (Sscore) against "gold standard" polysomnographically-determined apnoea/hypopnoea index (AHI), are reported both separately and combined. Four hundred and two patients suspected of SAS underwent full polysomnography recordings concomitantly with the use of the SleepStripTM.

For all samples combined, the correlation between AHI and Sscore was r=0.73, sensitivity and specificity values ranged from 80–86% and 57–86% respectively, and the area under the curve derived from receiver-operating characteristic curves ranged from 0.81–0.92 at varying AHI thresholds.

Though not intended as a substitute for polysomnography, the SleepStripTM may provide initial screening information, which may be useful in both clinical and experimental settings.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.